117 related articles for article (PubMed ID: 2178205)
1. Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC).
Weynants P; Humblet Y; Bosly A; Schallier D; Duprez P; Majois F; Beauduin M; Prignot J; Symann M
Med Oncol Tumor Pharmacother; 1990; 7(4):219-22. PubMed ID: 2178205
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
Comella P; Frasci G; De Cataldis G; Panza N; Cioffi R; Curcio C; Belli M; Bianco A; Ianniello G; Maiorino L; Della Vittoria M; Perchard J; Comella G
Br J Cancer; 1996 Dec; 74(11):1805-11. PubMed ID: 8956797
[TBL] [Abstract][Full Text] [Related]
3. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
Comella P; Scoppa G; Daponte A; Musetta G; Anania C; Maiorino A; Curcio C; Casaretti R; Comella G
Cancer; 1994 Oct; 74(7):1874-81. PubMed ID: 8082093
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
Figlin RA; Crowley JJ; Jacobs EL; Muirhead M; Goodwin JW; Rinehart JJ; Livingston RB
Cancer; 1996 Sep; 78(5):998-1003. PubMed ID: 8780537
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer.
Laohavinij S; Maoleekoonpairoj S; Cheirsilpa A; Maneechavakajorn J; Sirachainant E; Arpornvivat W; Jaisathaporn K; Ratanatharathorn V
Lung Cancer; 1999 Dec; 26(3):175-85. PubMed ID: 10598928
[TBL] [Abstract][Full Text] [Related]
6. Carboplatin plus oral etoposide in elderly patients with advanced non small cell lung cancer. A phase II study.
Gridelli C; Rossi A; Scognamiglio F; Guida C; Fiore F; Gatani T; Scoppa G; Pergola M
Anticancer Res; 1997; 17(6D):4755-8. PubMed ID: 9494602
[TBL] [Abstract][Full Text] [Related]
7. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer.
Scagliotti GV; Ricardi U; Crinó L; Maranzano E; De Marinis F; Morandi MG; Meacci L; Marangolo M; Emiliani E; Rosti G; Figoli F; Bolzicco G; Masiero P; Gentile A; Tonato M
Cancer Chemother Pharmacol; 1996; 38(6):561-5. PubMed ID: 8823499
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
[TBL] [Abstract][Full Text] [Related]
10. Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesothelioma.
White SC; Anderson H; Jayson GC; Ashcroft L; Ranson M; Thatcher N
Ann Oncol; 2000 Feb; 11(2):201-6. PubMed ID: 10761756
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer.
Masters GA; Hahn EA; Shevrin DH; Kies MS
Lung Cancer; 2003 Feb; 39(2):221-6. PubMed ID: 12581577
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: final analysis.
Bardet E; Rivière A; Charloux A; Spaeth D; Ducoloné A; Le Groumellec A; Pellae-Cosset B; Henry-Amar M; Douillard JY
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):163-8. PubMed ID: 9212019
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
[TBL] [Abstract][Full Text] [Related]
14. Dose-finding studies with carboplatin, ifosfamide, etoposide, and mesna in non-small cell lung cancer.
van Zandwijk N; ten Bokkel Huinink WW; Wanders J; Simonetti G; Dubbelman R; Franklin H; van Tinteren H; McVie JG
Semin Oncol; 1990 Feb; 17(1 Suppl 2):16-9. PubMed ID: 2154854
[TBL] [Abstract][Full Text] [Related]
15. Phase II studies with carboplatin in non-small cell lung cancer.
Gatzemeier U; Heckmayr M; Neuhauss R; Hossfeld D; Achterrath W; Lenaz L
Semin Oncol; 1990 Feb; 17(1 Suppl 2):25-31. PubMed ID: 2154856
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study).
Choy H; Devore RF; Hande KR; Porter LL; Rosenblatt P; Yunus F; Schlabach L; Smith C; Shyr Y; Johnson DH
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):931-7. PubMed ID: 10863062
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party.
Klastersky J; Sculier JP; Dabouis G; Bureau G; Libert P; Ravez P; Vandermoten G; Thiriaux J; Lecomte J; Cordier R
Semin Oncol; 1990 Feb; 17(1 Suppl 2):20-4. PubMed ID: 2154855
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.
Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Ozols RF
J Clin Oncol; 1995 Aug; 13(8):1860-70. PubMed ID: 7543559
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trial.
Johnson DH; DeVore R; Greco FA; Walls J; Thomas M; Hande KR; Hainsworth JD
Semin Oncol; 1992 Feb; 19(1 Suppl 2):50-6. PubMed ID: 1329223
[TBL] [Abstract][Full Text] [Related]
20. Response of brain metastases from lung cancer to systemic chemotherapy with carboplatin and etoposide.
Malacarne P; Santini A; Maestri A
Oncology; 1996; 53(3):210-3. PubMed ID: 8643223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
